Search

everythinglearnresearchcommunity

for

Search:↓

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib might be used to treat hair loss.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.